Reducing antibiotic prescriptions in children is not associated with higher rate of complications

Simona Di Mario1, Carlo Gagliotti2, Rossella Buttazzi2

  • 1Primary Care Service, Regional Health Authority of Emilia-Romagna, Viale Aldo Moro 21, 40127, Bologna, Italy. simona.dimario@regione.emilia-romagna.it.

Insights

Implementing guidelines for shorter antibiotic courses for acute otitis media and sore throat in children reduced antibiotic use without increasing serious complications like mastoiditis or rheumatic fever.

Area of Science:

  • Pediatric infectious diseases
  • Antimicrobial stewardship
  • Public health interventions

Background:

  • Acute otitis media (AOM) and streptococcal pharyngitis are frequent pediatric infections leading to antibiotic prescriptions.
  • Concerns about rare complications such as mastoiditis and acute rheumatic fever (ARF) can impede adherence to evidence-based guidelines.

Purpose of the Study:

  • To evaluate the impact of the ProBA project, which implemented evidence-based guidelines for antibiotic use in children.
  • To determine if reduced antibiotic prescribing rates were associated with increased rates of acute mastoiditis and ARF.

Main Methods:

  • Retrospective observational study using regional administrative databases (2005-2019).
  • Analysis of hospital admission rates for mastoiditis and ARF using ICD-9 codes.
  • Calculation of surgical intervention rates and antibiotic prescription trends via Poisson regression.

Main Results:

  • Antibiotic prescription rates decreased by 37% from 2005 to 2019.
  • Rates of mastoiditis diagnoses declined significantly (from 54.1 to 33.6 per 100,000).
  • Surgical treatment rates decreased, while ARF rates remained stable.

Conclusions:

  • The ProBA project's guidelines for short antibiotic courses were associated with reduced antibiotic consumption.
  • No increase in severe complications like mastoiditis or ARF was observed.
  • Administrative database analysis is valuable for monitoring public health projects and guideline adherence.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
122
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
131
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
125
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
150
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
100
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.7K